BACKGROUND AND OBJECTIVES: Hemodialysis (HD)-induced regional wall motion abnormalities (RWMAs) are common in HD patients and driven by ischemia. In nondialysis patients, repeated ischemia leads to chronic reduction in left ventricular (LV) function. HD-induced myocardial ischemia may initiate the same process. We examined the effect of HD-induced repetitive myocardial stunning on global and regional LV function. DESIGN, SETTING, PARTICIPANTS & MEASUREMENTS: We analyzed data from 30 patients, previously identified as developing HD-induced myocardial ischemia. Serial echocardiographic assessments of global and regional LV performance were performed at baseline and repeated after 12 mo. RESULTS: Several patients developed segments with a fixed reduction in systolic function of >60% after 1 yr. In this patient group, there was a significant reduction in resting LV ejection fraction (EF) from 61.5 +/- 10.1% to 52.9 +/- 8.6% (P < 0.007). Peak LV EF in response to dialysis also decreased from 59.5 +/- 10% versus 49.9 +/- 6.5% (P < 0.003), with a consequent increase in HD-induced hypotension (P < 0.0001). CONCLUSIONS: HD-induced myocardial stunning may progress over 12 mo to the development of regional fixed systolic dysfunction, consistent with underlying myocardial hibernation and fibrosis. This may be an important and potentially modifiable process in the development of heart failure in HD patients.
BACKGROUND AND OBJECTIVES: Hemodialysis (HD)-induced regional wall motion abnormalities (RWMAs) are common in HDpatients and driven by ischemia. In nondialysis patients, repeated ischemia leads to chronic reduction in left ventricular (LV) function. HD-induced myocardial ischemia may initiate the same process. We examined the effect of HD-induced repetitive myocardial stunning on global and regional LV function. DESIGN, SETTING, PARTICIPANTS & MEASUREMENTS: We analyzed data from 30 patients, previously identified as developing HD-induced myocardial ischemia. Serial echocardiographic assessments of global and regional LV performance were performed at baseline and repeated after 12 mo. RESULTS: Several patients developed segments with a fixed reduction in systolic function of >60% after 1 yr. In this patient group, there was a significant reduction in resting LV ejection fraction (EF) from 61.5 +/- 10.1% to 52.9 +/- 8.6% (P < 0.007). Peak LV EF in response to dialysis also decreased from 59.5 +/- 10% versus 49.9 +/- 6.5% (P < 0.003), with a consequent increase in HD-induced hypotension (P < 0.0001). CONCLUSIONS:HD-induced myocardial stunning may progress over 12 mo to the development of regional fixed systolic dysfunction, consistent with underlying myocardial hibernation and fibrosis. This may be an important and potentially modifiable process in the development of heart failure in HDpatients.
Authors: J Narula; M S Dawson; B K Singh; A Amanullah; E R Acio; F A Chaudhry; R B Arani; A E Iskandrian Journal: J Am Coll Cardiol Date: 2000-11-15 Impact factor: 24.094
Authors: Jacques Blacher; Michel E Safar; Alain P Guerin; Bruno Pannier; Sylvain J Marchais; Gérard M London Journal: Kidney Int Date: 2003-05 Impact factor: 10.612
Authors: W J Bos; S Bruin; R W van Olden; I Keur; K H Wesseling; N Westerhof; R T Krediet; L A Arisz Journal: Am J Kidney Dis Date: 2000-05 Impact factor: 8.860
Authors: Jose Jayme G De Lima; Emil Sabbaga; Marcelo Luis C Vieira; Flavio J de Paula; Luis E Ianhez; Eduardo M Krieger; Jose Antonio F Ramires Journal: Hypertension Date: 2003-08-11 Impact factor: 10.190
Authors: James O Burton; Helen J Jefferies; Nicholas M Selby; Christopher W McIntyre Journal: Clin J Am Soc Nephrol Date: 2009-04-08 Impact factor: 8.237
Authors: Christopher W McIntyre; Laura E A Harrison; M Tarek Eldehni; Helen J Jefferies; Cheuk-Chun Szeto; Stephen G John; Mhairi K Sigrist; James O Burton; Daljit Hothi; Shvan Korsheed; Paul J Owen; Ka-Bik Lai; Philip K T Li Journal: Clin J Am Soc Nephrol Date: 2010-09-28 Impact factor: 8.237
Authors: Gürsel Yildiz; Mansur Kayataş; Ferhan Candan; Mehmet Birhan Yilmaz; Ali Zorlu; Savaş Sarikaya Journal: Cardiorenal Med Date: 2013-06-25 Impact factor: 2.041
Authors: Christopher T Chan; Glenn M Chertow; John T Daugirdas; Tom H Greene; Peter Kotanko; Brett Larive; Andreas Pierratos; John B Stokes Journal: Nephrol Dial Transplant Date: 2013-09-26 Impact factor: 5.992
Authors: Stephen M S Ting; Hasan Iqbal; Hemali Kanji; Thomas Hamborg; Nicolas Aldridge; Nithya Krishnan; Chris H E Imray; Prithwish Banerjee; Rosemary Bland; Robert Higgins; Daniel Zehnder Journal: J Am Soc Nephrol Date: 2013-11-14 Impact factor: 10.121